MF houses
Aug 20260no change m/m
No tracked fund house held PANACEABIO in Aug 2026.
AMC portfolios, Aug 2026 · 20 AMCs trackedSource: AMC monthly portfolios (SEBI disclosure)
0 fund houses →
Panacea Biotec Limited
₹372.60NSE close, 25 Sep 2026
Data as of10 sources, each card shows its own date
MF: Aug 2026 portfolios (monthly), 20 AMCsShares outstanding and close: NSE, 25 Sep 2026Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collectedDeals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026SLBM: NSE, 25 Sep 2026 · 30 days collectedMTF: NSE, 24 Sep 2026 · 29 days collectedFlags: NSE, 25 Sep 2026FPI: Shareholding pattern as of 30 Jun 2026, filed 21 Jul 2026Pledge: Shareholding pattern as of 30 Jun 2026Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF holding, % of equity
0.00%▼ −0.00 pp
Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes
FPI holding, % of equity
2.31%
as of 30 Jun 2026
Fund houses holding
0no change
0 entered, 0 exited · Aug 2026 · index funds hidden
Promoter pledge
0.00%
as of 30 Jun 2026
What changed
No tracked fund house held PANACEABIO in Aug 2026 (20 AMCs tracked).
Named FPIs at 1% or more
as of 30 Jun 20262.31%
FPI category I + II, % of total shares · 1 named at 1% or more
FPIs named at 1% or more on 30 Jun 2026: Massachusetts Institute of Technology 1.71%.
Shareholding pattern as of 30 Jun 2026, filed 21 Jul 2026Source: NSE shareholding pattern filings (XBRL), quarterly
Insider and promoter
29 Jun 2026 to 26 Sep 20261▼ net −3,000 sh
disclosed transactions · equity bought 0 sh, sold 3,000 sh
Latest: Nosheen Sheikh (Employees Immediate Relative), Sell 3,000 Equity worth ₹12,28,918, 20 Aug 2026, Market Sale.
Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)Source: NSE insider trading disclosures (SEBI PIT, XBRL)
Bulk and block deals
25 Sep 2026No bulk or block deals in PANACEABIO on 25 Sep 2026.
NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026Source: NSE bulk.csv and block.csv, daily
Promoter pledge
as of 30 Jun 20260.00%
of promoter holding · 0.00% of total shares
Promoters had pledged 0 of their 4.44 cr shares on 30 Jun 2026.
Shareholding pattern as of 30 Jun 2026Source: NSE shareholding pattern filings (XBRL), quarterly
SLBM borrowing
25 Sep 2026NSE listed no SLBS open position for PANACEABIO on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026. No SLBM trades in PANACEABIO on 25 Sep 2026.
NSE, 25 Sep 2026 · 30 days collectedSource: NSE SLBS open positions (slb_openpos) and SLBM bhavcopy (SLBM_BC), daily
MTF book
24 Sep 20264.28 lakh sh▲ +1,189 vs 23 Sep 2026
percentile 21 of 29 days collected · ₹19.6 cr financed
4.28 lakh shares, 0.70% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 21 of 29 days collected.
NSE, 24 Sep 2026 · 29 days collectedSource: NSE margin trading disclosure (mrg_trading), daily
Delivery
25 Sep 202642.0%▼ −10.5 pp vs 20-day average
20-day average 52.5% · percentile 17 of 30 days collected
42.0% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 52.5%; that day sits at percentile 17 of 30 days collected.
NSE bhavcopy, 25 Sep 2026 · 30 days collectedSource: NSE security-wise delivery file (sec_bhavdata_full), daily
Red flags
25 Sep 2026No F&O
PANACEABIO has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed PANACEABIO under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.
NSE, 25 Sep 2026Source: NSE F&O ban file, combined OI (MWPL), surveillance indicators (REG1_IND), daily